Rekombinante Antikörper als Alternativen in Forschung und Diagnostik

Despite readily available alternative technologies, many antibodies in research and diagnostics are still generated and produced with the use of laboratory animals. Here, we portrait the concept of animal-free recombinant antibodies and the generation of such an antibody against the spike-protein of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenzel, Esther Veronika, Zilkens, Kilian Johannes Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Anwendungen & Produkte
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960684/
https://www.ncbi.nlm.nih.gov/pubmed/35369108
http://dx.doi.org/10.1007/s12268-022-1716-7
_version_ 1784677430850486272
author Wenzel, Esther Veronika
Zilkens, Kilian Johannes Carl
author_facet Wenzel, Esther Veronika
Zilkens, Kilian Johannes Carl
author_sort Wenzel, Esther Veronika
collection PubMed
description Despite readily available alternative technologies, many antibodies in research and diagnostics are still generated and produced with the use of laboratory animals. Here, we portrait the concept of animal-free recombinant antibodies and the generation of such an antibody against the spike-protein of SARS-Cov-2. The scientific community needs to raise awareness for more sustainable animal-free alternatives, especially as they offer a path to more reliable and reproducible data.
format Online
Article
Text
id pubmed-8960684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89606842022-03-29 Rekombinante Antikörper als Alternativen in Forschung und Diagnostik Wenzel, Esther Veronika Zilkens, Kilian Johannes Carl Biospektrum (Heidelb) Anwendungen & Produkte Despite readily available alternative technologies, many antibodies in research and diagnostics are still generated and produced with the use of laboratory animals. Here, we portrait the concept of animal-free recombinant antibodies and the generation of such an antibody against the spike-protein of SARS-Cov-2. The scientific community needs to raise awareness for more sustainable animal-free alternatives, especially as they offer a path to more reliable and reproducible data. Springer Berlin Heidelberg 2022-03-28 2022 /pmc/articles/PMC8960684/ /pubmed/35369108 http://dx.doi.org/10.1007/s12268-022-1716-7 Text en © Springer-Verlag GmbH 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Anwendungen & Produkte
Wenzel, Esther Veronika
Zilkens, Kilian Johannes Carl
Rekombinante Antikörper als Alternativen in Forschung und Diagnostik
title Rekombinante Antikörper als Alternativen in Forschung und Diagnostik
title_full Rekombinante Antikörper als Alternativen in Forschung und Diagnostik
title_fullStr Rekombinante Antikörper als Alternativen in Forschung und Diagnostik
title_full_unstemmed Rekombinante Antikörper als Alternativen in Forschung und Diagnostik
title_short Rekombinante Antikörper als Alternativen in Forschung und Diagnostik
title_sort rekombinante antikörper als alternativen in forschung und diagnostik
topic Anwendungen & Produkte
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960684/
https://www.ncbi.nlm.nih.gov/pubmed/35369108
http://dx.doi.org/10.1007/s12268-022-1716-7
work_keys_str_mv AT wenzelestherveronika rekombinanteantikorperalsalternativeninforschungunddiagnostik
AT zilkenskilianjohannescarl rekombinanteantikorperalsalternativeninforschungunddiagnostik

Ejemplares similares